Elevated serum CA-125 concentrations due to expression by a diffuse large B-cell lymphoma

Annals of Clinical Biochemistry

Volumn 37, Issue 4, 2000, Pages 545-548

  Vlasveld, L Th ^a   Ermens, A A M ^a   Sonnenberg, A A ^a   Pauwels, P ^b  

^a Department of Internal Medicine ^*  (Netherlands)

^b Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BONE LESION; CANCER STAGING; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0033932679     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563001899564     Document Type: Article

References (12)

1. Kenemans P, Bast R, Yedema C, Price M, Hilgers J. CA 125 and polymorphic epithelial mucin as serum tumor markers. Cancer Rev 1988; 11/12: 119-44
2. Pabst T, Ludwig C. CA-125: A tumor marker in Non-Hodgkin's lymphomas? J Clin Oncol 1995; 13: 1827-8
3. Pabst T, Ludwig Ch. CA-125 - a tumour marker? [in German] Schweiz Med Wochenschr 1995; 125: 1195-200
4. Ravoet C, Dargent J-L, Le Moine L, Feremans W. CA-125 in primary mediastinal B-cell lymphoma with sclerosis. J Clin Oncol 1995; 13: 530-1
5. Buhl CH, Füllbrandt U, Pompecki R, Frenzel H. CA-125 and CA 19-9 in non-Hodgkin's lymphoma [in German]. Dtsch Med Wochenschr 1986; 111: 921-2
6. Sebban C, Lasne Y, Berenguer V, Archimbaud E, Decaux Y, Viala JJ. CA 125 and malignant lymphomas. J Clin Oncol 1991; 9: 359-60
7. Apel RL, Fernandes SJ. Malignant lymphoma presenting with an elevated serum CA-125 level. Arch Pathol Lab Med 1995; 119: 373-6
8. Benboubker L, Linassier C, Ollivier I, Delain M, Valat C, Fetissof F. S-CA125 and LDH levels as a new prognostic index in patients with non-Hodgkin's lymphomas. Blood 1996; 88(suppl 1): 224a
9. Lazzarino M, Orlandi E, Klersy C, Astori C, Brusamolino E, Corso A. Serum CA-125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. Cancer 1998; 82: 576-82
10. Kubonishi I, Bandobashi K, Murata N, Daibata M, Ido E, Sonobe H. High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol 1997; 98: 450-2
11. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92
12. De Mascarel A, Merlio IP, Coindre JM, Goussot JF, Broustet A. A gastric large cell lymphoma expressing cytokeratin but no leucocyte common antigen. A diagnostic dilemma. Am J Clin Pathol 1989; 91: 478-81